Heather L. Gardner

1.2k total citations
34 papers, 716 citations indexed

About

Heather L. Gardner is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Heather L. Gardner has authored 34 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 13 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Heather L. Gardner's work include Veterinary Oncology Research (20 papers), Virus-based gene therapy research (12 papers) and Infectious Diseases and Mycology (5 papers). Heather L. Gardner is often cited by papers focused on Veterinary Oncology Research (20 papers), Virus-based gene therapy research (12 papers) and Infectious Diseases and Mycology (5 papers). Heather L. Gardner collaborates with scholars based in United States, Canada and Denmark. Heather L. Gardner's co-authors include Cheryl A. London, Joelle M. Fenger, Lilla Di Scala, Jean‐Yves Douillard, Jean‐Charles Soria, Giuseppe Giaccone, Lucio Crinò, J. Wolf, Federico Cappuzzo and Frances A. Shepherd and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Heather L. Gardner

32 papers receiving 707 citations

Peers

Heather L. Gardner
Joelle M. Fenger United States
Cecília Bonolo de Campos Brazil
Xun Cai China
Mee-Sook Roh South Korea
J Y Ro United States
Pradip Nair India
Matthew D. Stachler United States
Cynthia Bedell United States
Han‐Ik Bae South Korea
Θεόδωρος Ράμπιας Greece
Joelle M. Fenger United States
Heather L. Gardner
Citations per year, relative to Heather L. Gardner Heather L. Gardner (= 1×) peers Joelle M. Fenger

Countries citing papers authored by Heather L. Gardner

Since Specialization
Citations

This map shows the geographic impact of Heather L. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather L. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather L. Gardner more than expected).

Fields of papers citing papers by Heather L. Gardner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather L. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather L. Gardner. The network helps show where Heather L. Gardner may publish in the future.

Co-authorship network of co-authors of Heather L. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Heather L. Gardner. A scholar is included among the top collaborators of Heather L. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather L. Gardner. Heather L. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterson, Cornelia, Elinor K. Karlsson, William C. Eward, et al.. (2025). Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma. PLoS ONE. 20(6). e0325181–e0325181. 1 indexed citations
2.
Heiden, A., Heather L. Gardner, William P.D. Hendricks, et al.. (2025). Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival. Scientific Reports. 15(1). 4724–4724.
3.
Avery, Anne C., et al.. (2024). Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma. Journal of Veterinary Internal Medicine. 38(3). 1666–1674. 5 indexed citations
4.
Piedra-Mora, César, Linda M. Wrijil, Clément N. David, et al.. (2023). Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma. Frontiers in Veterinary Science. 10. 1225764–1225764. 2 indexed citations
5.
Gardner, Heather L., et al.. (2023). Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma. PLoS ONE. 18(8). e0290428–e0290428. 7 indexed citations
6.
London, Cheryl A., Heather L. Gardner, Shaying Zhao, et al.. (2023). Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology. Veterinary and Comparative Oncology. 21(4). 565–577. 11 indexed citations
7.
Megquier, Kate, Jason Turner-Maier, Kathleen M. Morrill, et al.. (2022). The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations. PLoS ONE. 17(9). e0274383–e0274383. 7 indexed citations
8.
Gardner, Heather L., et al.. (2019). TRANSLATOR Database—A Vision for a Multi-Institutional Research Network. Topics in companion animal medicine. 37. 100363–100363. 1 indexed citations
9.
Gardner, Heather L., et al.. (2019). Optimization of Electronic Medical Records for Data Mining Using a Common Data Model. Topics in companion animal medicine. 37. 100364–100364. 7 indexed citations
10.
Gardner, Heather L., et al.. (2019). Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study. BMC Veterinary Research. 15(1). 291–291. 7 indexed citations
11.
London, Cheryl A., Jaime Acquaviva, Donald L. Smith, et al.. (2018). Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors. Clinical Cancer Research. 24(24). 6396–6407. 8 indexed citations
12.
Gardner, Heather L., Misty D. Bear, Kim Cronin, et al.. (2018). Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma. PLoS ONE. 13(4). e0195357–e0195357. 13 indexed citations
13.
Gardner, Heather L., et al.. (2017). Safety and efficacy of targeted hyperthermia treatment utilizing gold nanorod therapy in spontaneous canine neoplasia. BMC Veterinary Research. 13(1). 294–294. 14 indexed citations
14.
London, Cheryl A., Heather L. Gardner, Gerald Post, et al.. (2016). KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells. Clinical Cancer Research. 23(10). 2565–2574. 29 indexed citations
15.
Harrington, Bonnie K., Heather L. Gardner, Raquel Izumi, et al.. (2016). Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma. PLoS ONE. 11(7). e0159607–e0159607. 43 indexed citations
16.
Gardner, Heather L., Sandra Nguyen, Wm Tod Drost, et al.. (2016). A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma. BMC Veterinary Research. 12(1). 257–257. 21 indexed citations
17.
Gardner, Heather L., Cheryl A. London, Sandra Nguyen, et al.. (2015). Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma. BMC Veterinary Research. 11(1). 131–131. 35 indexed citations
18.
Lerche, Phillip, et al.. (2015). The effects of preoperative oral administration of carprofen or tramadol on postoperative analgesia in dogs undergoing cutaneous tumor removal.. PubMed. 56(8). 817–22. 12 indexed citations
19.
Gardner, Heather L., et al.. (2014). What Is Your Diagnosis?. Journal of the American Veterinary Medical Association. 244(9). 1031–1032. 1 indexed citations
20.
Soria, Jean‐Charles, Frances A. Shepherd, Jean‐Yves Douillard, et al.. (2009). Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Annals of Oncology. 20(10). 1674–1681. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joelle M. Fenger Breakdown of academic impact, for papers by Cecília Bonolo de Campos Breakdown of academic impact, for papers by Xun Cai Breakdown of academic impact, for papers by Mee-Sook Roh Breakdown of academic impact, for papers by J Y Ro Breakdown of academic impact, for papers by Pradip Nair Breakdown of academic impact, for papers by Matthew D. Stachler Breakdown of academic impact, for papers by Cynthia Bedell Breakdown of academic impact, for papers by Han‐Ik Bae Breakdown of academic impact, for papers by Θεόδωρος Ράμπιας
Rankless by CCL
2026